Markers of Minimal Residual Disease
- 1 January 1982
- book chapter
- Published by Springer Nature
- Vol. 80, 17-21
- https://doi.org/10.1007/978-3-642-81685-7_3
Abstract
Current methods employing tumour markers to detect small amounts of residual disease are reviewed with respect to human germ cell, colorectal and breast neoplasms. It is concluded that the assay of tumour markers in body fluids has only limited clinical value. Alternative approaches, such as are afforded by radioimmu nodetection and immunocytochemistry, are presented and critically appraised.Keywords
This publication has 11 references indexed in Scilit:
- ASSESSMENT OF BIOCHEMICAL TESTS TO SCREEN FOR METASTASES IN PATIENTS WITH BREAST CANCER*1The Lancet, 1980
- Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.BMJ, 1980
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences, 1979
- A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancerThe American Journal of Surgery, 1979
- A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.Journal of Clinical Pathology, 1979
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978
- Carcinoembryonic Antigen Test for Recurrent Colorectal CarcinomaPublished by American Medical Association (AMA) ,1978
- Biochemical Monitoring of Cancer: A ReviewAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1976
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Recent Observations Related To The Chemotherapy And Immunology Of Gestational ChoriocarcinomaAdvances in Cancer Research, 1973